Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1993 May;83(5):649–654. doi: 10.2105/ajph.83.5.649

The dual epidemics of tuberculosis and AIDS: ethical and policy issues in screening and treatment.

R Bayer 1, N N Dubler 1, S Landesman 1
PMCID: PMC1694697  PMID: 8484443

Abstract

As the recent increase in cases of tuberculosis is addressed, there is a danger that the need for increased protection of the public health will create a climate in which the rights of individuals with tuberculosis and human immunodeficiency virus (HIV) infection may be disregarded. This paper considers ethical and policy issues in the control of tuberculosis. The authors conclude that mandatory HIV testing is not critical to effective tuberculosis control, and that although individuals infected with HIV are at increased risk for developing tuberculosis, exclusionary employment practices are not justified. Because failure to complete the course of tuberculosis treatment increases the prospect that drug-resistant strains will develop, it is crucial to require all those who commence treatment to complete their therapy. To ensure the completion of treatment, special attention must be paid to the needs of the homeless, drug users, and those with psychiatric impairments. In addition, all tuberculosis patients should begin their posthospital care under direct observation. Patients who fail to complete treatment despite efforts to encourage and facilitate their cooperation should be subject to confinement after a hearing with full due process protections.

Full text

PDF
652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addington W. W. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest. 1979 Dec;76(6 Suppl):741–743. doi: 10.1378/chest.76.6_supplement.741. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. F., Bloch A. B., Davidson P. T., Snider D. E., Jr Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991 Jun 6;324(23):1644–1650. doi: 10.1056/NEJM199106063242307. [DOI] [PubMed] [Google Scholar]
  3. Bayer R. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? N Engl J Med. 1991 May 23;324(21):1500–1504. doi: 10.1056/NEJM199105233242111. [DOI] [PubMed] [Google Scholar]
  4. Bloom B. R., Murray C. J. Tuberculosis: commentary on a reemergent killer. Science. 1992 Aug 21;257(5073):1055–1064. doi: 10.1126/science.257.5073.1055. [DOI] [PubMed] [Google Scholar]
  5. Braun M. M., Truman B. I., Maguire B., DiFerdinando G. T., Jr, Wormser G., Broaddus R., Morse D. L. Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA. 1989 Jan 20;261(3):393–397. [PubMed] [Google Scholar]
  6. Brudney K., Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Semin Respir Infect. 1991 Dec;6(4):261–272. [PubMed] [Google Scholar]
  7. Brudney K., Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991 Oct;144(4):745–749. doi: 10.1164/ajrccm/144.4.745. [DOI] [PubMed] [Google Scholar]
  8. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  9. Eisenstat Steven. An analysis of the rationality of mandatory testing for the HIV antibody: balancing the governmental public health interests with the individual's privacy interest. Univ Pittsbg Law Rev. 1991 Winter;52(2):327–382. [PubMed] [Google Scholar]
  10. Etkind S., Boutotte J., Ford J., Singleton L., Nardell E. A. Treating hard-to-treat tuberculosis patients in Massachusetts. Semin Respir Infect. 1991 Dec;6(4):273–282. [PubMed] [Google Scholar]
  11. Fischl M. A., Uttamchandani R. B., Daikos G. L., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Lai S. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177–183. doi: 10.7326/0003-4819-117-3-177. [DOI] [PubMed] [Google Scholar]
  12. Gerbert B., Maguire B. T., Bleecker T., Coates T. J., McPhee S. J. Primary care physicians and AIDS. Attitudinal and structural barriers to care. JAMA. 1991 Nov 27;266(20):2837–2842. [PubMed] [Google Scholar]
  13. Gostin L. O. Controlling the resurgent tuberculosis epidemic. A 50-state survey of TB statutes and proposals for reform. JAMA. 1993 Jan 13;269(2):255–261. doi: 10.1001/jama.269.2.255. [DOI] [PubMed] [Google Scholar]
  14. MOHLER D. N., WALLIN D. G., DREYFUS E. G. Studies in the home treatment of streptococcal disease. I. Failure of patients to take penicillin by mouth as prescribed. N Engl J Med. 1955 Jun 30;252(26):1116–1118. doi: 10.1056/NEJM195506302522604. [DOI] [PubMed] [Google Scholar]
  15. Pearson M. L., Jereb J. A., Frieden T. R., Crawford J. T., Davis B. J., Dooley S. W., Jarvis W. R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med. 1992 Aug 1;117(3):191–196. doi: 10.7326/0003-4819-117-3-191. [DOI] [PubMed] [Google Scholar]
  16. Sackett D. L., Haynes R. B., Gibson E. S., Hackett B. C., Taylor D. W., Roberts R. S., Johnson A. L. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975 May 31;1(7918):1205–1207. doi: 10.1016/s0140-6736(75)92192-3. [DOI] [PubMed] [Google Scholar]
  17. Sbarbaro J. A. Compliance: inducements and enforcements. Chest. 1979 Dec;76(6 Suppl):750–756. doi: 10.1378/chest.76.6_supplement.750. [DOI] [PubMed] [Google Scholar]
  18. Sbarbaro J. A. Public health aspects of tuberculosis: supervision of therapy. Clin Chest Med. 1980 May;1(2):253–263. [PubMed] [Google Scholar]
  19. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  20. Shewell K. W. The surgeon and the HIV-infected patient. JAMA. 1990 Sep 19;264(11):1407–1408. doi: 10.1001/jama.1990.03450110053015. [DOI] [PubMed] [Google Scholar]
  21. Snider D. E., Jr, Roper W. L. The new tuberculosis. N Engl J Med. 1992 Mar 5;326(10):703–705. doi: 10.1056/NEJM199203053261011. [DOI] [PubMed] [Google Scholar]
  22. Torres R. A., Mani S., Altholz J., Brickner P. W. Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med. 1990 Oct;150(10):2030–2036. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES